Congress

Over the past decade, catheter based treatments of an increasing variety of cardiac diseases have expanded dramatically. These advancements became available through new developments and improvements in available devices, as well as increasing the innovation and progress in imaging techniques. Successful completion of any catheter-based treatment for structural heart disease depends on a combination of multiple factors: accurate assessment of the nature of the defect to be treated, appropriate patient selection and procedural planning, quality of the intraprocedural echocardiographic navigation, complication avoidance during the procedure and close patient follow-up. Each of these steps heavily relies on accurate imaging, in particular in echocardiography.

The congress will offer a practical educational forum, focusing the content on the role of echocardiography and cardiac imaging within the structural heart team. This event will involve multidisciplinary experts in interventional echocardiography, interventional cardiology, cardiac imaging and cardiac surgery – all engaged in the heart valve team approach to structural heart disease.

The program will be composed of various educational formats including:

  • didactic Lectures
  • case presentations
  • workshops (Imaging Techniques; Procedural Imaging Guidance; Devices  Interaction with Echo simulators)
  • live cases

The Interventional Echocardiographic Congress is designed for cardiologists, cardiac imaging experts, interventional cardiologists, cardiac anesthesiologists, cardiac surgeons, who are involved in catheter-based therapies for structural heart disease.

  • Illustrate the most common and the new transcatheter therapeutic options for structural heart diseases
  • Show the latest imaging techniques for procedural planning and intraprocedural monitoring
  • Discuss patient selection and procedural planning: which patient for which procedure
  • Demonstrate procedure-specific imaging needs
  • Recognize potential complications of percutaneous interventions for structural heart disease